These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 16570152)

  • 1. Bone marrow necrosis associated with the use of imatinib mesylate in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Matsue K; Takeuchi M; Koseki M; Uryu H
    Ann Hematol; 2006 Aug; 85(8):542-4. PubMed ID: 16570152
    [No Abstract]   [Full Text] [Related]  

  • 2. Diminished alpha2-plasmin inhibitor activity associated with the use of imatinib mesylate in patients with Philadelphia chromosome-positive haematologic cancer.
    Matsue K; Matsuo K; Fujiwara H; Iwama K; Hayama BY; Kimura S; Yamakura M; Takeuch M
    Thromb Haemost; 2009 Jun; 101(6):1170-1. PubMed ID: 19492163
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of dasatinib in the patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia with resistance to imatinib and renal failure.
    Sonmez M; Cobanoglu U; Ovali E; Omay SB
    J Clin Pharm Ther; 2008 Jun; 33(3):329-30. PubMed ID: 18452422
    [No Abstract]   [Full Text] [Related]  

  • 4. Gelatinous transformation of the bone marrow as a late morphological change in imatinib mesylate treated chronic myeloid leukaemia.
    Hong FS; Mitchell CA; Zantomio D
    Pathology; 2010 Jan; 42(1):84-5. PubMed ID: 20025487
    [No Abstract]   [Full Text] [Related]  

  • 5. Bone marrow necrosis secondary to imatinib usage, mimicking spinal metastasis on magnetic resonance imaging and FDG-PET/CT.
    Aras Y; Akcakaya MO; Unal SN; Bilgic B; Unal OF
    J Neurosurg Spine; 2012 Jan; 16(1):57-60. PubMed ID: 22017257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemorrhagic complications associated with reduced alpha2-plasmin inhibitor during imatinib use in a patient with Philadelphia chromosome-positive acute lymphoblastic leukaemia.
    Matsue K; Aoki T; Odawara J; Kimura S; Yamakura M; Takeuchi M
    Leuk Res; 2009 Jun; 33(6):867-9. PubMed ID: 18951628
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone marrow necrosis related to imatinib mesylate therapy for cml bilineal blast crisis.
    Campiotti L; Codari R; Appio L; Ultori C; Solbiati F; Maria Grandi A; Venco A
    Leuk Res; 2007 Dec; 31(12):1768-70. PubMed ID: 17403537
    [No Abstract]   [Full Text] [Related]  

  • 8. Adverse events after imatinib mesylate therapy.
    Burton C; Azzi A; Kerridge I
    N Engl J Med; 2002 Feb; 346(9):712-3. PubMed ID: 11873781
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hypoprotidemia may explain imatinib intoxication in a patient with Philadelphia-positive acute lymphoblastic leukemia].
    Gaïes E; Trabelsi S; Sahnoun R; Salouage I; Jebabli N; Charfi R; Lakhal M; Hdiji S; Klouz A
    Therapie; 2013; 68(2):125-7. PubMed ID: 23773356
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pediatric acute lymphoblastic leukemia initially presenting with bone marrow necrosis].
    Kato M; Kikuchi A; Oshima K; Yamamoto S; Mochizuki S; Arai K; Hanada R
    Rinsho Ketsueki; 2007 Feb; 48(2):140-3. PubMed ID: 17370642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib mesylate as a cause of acute liver failure.
    Cross TJ; Bagot C; Portmann B; Wendon J; Gillett D
    Am J Hematol; 2006 Mar; 81(3):189-92. PubMed ID: 16493605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib-related bone marrow aplasia after complete cytogenetic response in chronic myeloid leukemia.
    Khan KA; Junaid A; Siddiqui NS; Mukhtar K; Siddiqui S
    J Coll Physicians Surg Pak; 2008 Mar; 18(3):176-8. PubMed ID: 18460249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imatinib-induced Severe Hepatitis in a 9-Year-old Girl With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia.
    Suzuki R; Kobayashi C; Sakai A; Fukushima H; Tagawa M; Satomi K; Nanmoku T; Sumazaki R; Fukushima T
    J Pediatr Hematol Oncol; 2015 Aug; 37(6):e368-71. PubMed ID: 25929609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib mesylate in combination with chemotherapy in four children with de novo and advanced stage Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Fuster JL; Bermúdez M; Galera A; Llinares ME; Calle D; Ortuño FJ
    Haematologica; 2007 Dec; 92(12):1723-4. PubMed ID: 18056006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subdural hematomas in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia receiving imatinib mesylate in conjunction with systemic and intrathecal chemotherapy.
    Patel SB; Gojo I; Tidwell ML; Sausville EA; Baer MR
    Leuk Lymphoma; 2011 Jul; 52(7):1211-4. PubMed ID: 21534873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor lysis syndrome after STI571 in Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Dann EJ; Fineman R; Rowe JM
    J Clin Oncol; 2002 Jan; 20(1):354-5. PubMed ID: 11773197
    [No Abstract]   [Full Text] [Related]  

  • 17. Prominent pleural effusion possibly due to imatinib mesylate in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
    Ishii Y; Shoji N; Kimura Y; Ohyashiki K
    Intern Med; 2006; 45(5):339-40. PubMed ID: 16596010
    [No Abstract]   [Full Text] [Related]  

  • 18. Vitiligo-like lesions in an adult patient treated with Imatinib mesylate.
    Cerchione C; Fabbricini R; Pane F; Luciano L
    Leuk Res; 2009 Aug; 33(8):e104-5. PubMed ID: 19232719
    [No Abstract]   [Full Text] [Related]  

  • 19. Systemic Mastocytosis: documented pathologic response to imatinib.
    Gollard RP; Ruemmler-Fish C; Garcia D
    Eur J Haematol; 2007 Oct; 79(4):367-8. PubMed ID: 17655701
    [No Abstract]   [Full Text] [Related]  

  • 20. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).
    Burke MJ; Cao Q; Trotz B; Weigel B; Kumar A; Smith A; Verneris MR
    Pediatr Blood Cancer; 2009 Dec; 53(7):1289-94. PubMed ID: 19731318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.